CLINICAL INDICATION
SPINAL CORD INJURY
Following spinal injury and trauma, there may be a rupture of the spinal cord nerve pathways carrying signals to and from the brain, resulting in loss of mobility and sensation. A natural partial recovery is possible after a trauma of sort, but many times no further progress is recorded beyond the first year: This is the chronic stage.
​
Apart from neurostimulation systems or exoskeletons under development and which only treat the mobility part of paraplegia, there is no solution which allows paraplegic patients to heal their disability in all its dimensions.
​
Traditional clinical treatment is based on anti-inflammatory agents, surgical intervention for stabilization of the spinal cord and intensive rehabilitation to help maintain strength, all of which are ineffective in tissue regeneration and function restoration.
The problem facing practitioners is that there is no way to restore the original nervous circuits responsible for the transmission of nerve impulses, an essential step in regaining mobility and sensitivity.
Patients suffering from chronic functional motor disabilities along with their medical specialists are in high expectation of therapeutic innovation. At present, there are 2.5 million spinal cord injury patients worldwide, including 720,000 complete paraplegic patients in the chronic stage with an increase of 100,000 new cases per year.
Now NBM's SPINEREP technology will be able to contribute to the relief and improvement of the physical state of many patients by offering hope through its new medical solution.
​
THE PATIENT'S JOURNEY
After approval from the patient's neurosurgeon and muscle preparation is complete, the patient is operated on in a meticulous yet standard surgical procedure. During the intervention, the SPINEREP device is positioned at the level of the lesion and integrates perfectly into the spinal cord. Its porous structure allows cell and vascular colonization and supports the regrowth of nerve fibers. No sutures are required as SPINEREP is naturally bio-adhesive.
The patient then undergoes an intensive rehabilitation phase for approximately 12 months in order to optimize the chances of a functional recovery and to significantly increase their musculo-tendon capacities.